MARLENA MIMS: Open Payments
NPI 1922435130 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 20 payments from 10 companies in 2025. Trend: 2023 $232 · 2024 $199 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $78 |
| Hologic Sales and Service, LLC | 3 | $54 |
| Organon LLC | 4 | $47 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $44 |
| Exeltis, USA Inc. | 2 | $41 |
| Sage Therapeutics, LLC | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: Veozah, MYOSURE TISSUE REMOVAL DEVICE, SLYND, NEXPLANON, JADA SYSTEM, ZURZUVAE, Qelbree, JOURNAVX.
Industry payments across MS — which companies pay providers there.
